Revenue ($m) 31.6, up 7.8pc from year-earlier 29.3
Pre-tax profit ($m) 18.2 v 14.8
Net profit ($m) 13.5 v 12.1
Interim dividend (¢) 7 v 6, payable March 19
Medical imaging technology company Pro Medicus expects 2022 to be a transformative year – chief executive Sam Hupert says that is when the gains from its latest flood of contracts will flow through.
Speaking to The Australian Financial Review following the release of the company’s results for the six months ended December 31, Dr Hupert said that even if the company did not do another deal this year, it would have plenty of growth potential.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
